Clinical Trial Update: Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating GTX (gemcitabine/taxotere/xeloda) with cisplatin and irinotecan in metastatic pancreatic adenocarcinoma; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• GTX (gemcitabine/taxotere/xeloda)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-09-14